You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A FAP-Activated Proteasome Inhibitor for Killing Solid Tumors
SBC: ARISAPH PHARMACEUTICALS, INC. Topic: 102DESCRIPTION provided by applicant Cancer is the second leading cause of death after heart disease in the US Chemotherapy is a mainstay of treatment after surgical removal of tumors but the balance of clinical benefit versus disabling or life threatening side effects is often uncertain Genotyping of cancers to identify mutated oncogenes has enabled an era of targeted therapy Drugs targeting ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
A Novel Approach to Assessing Cognitive State During Real-World Tasks
SBC: ADVANCED BRAIN MONITORING, INC. Topic: 105DESCRIPTION provided by applicant In Phase our team was able to enhance the ABM B Alert system for use in on the road evaluations by reducing the overall profile of the hardware system introducing real time commenting for marking events in real world activities and assessing and confirming current artifact rejection algorithms for sufficiency in real world environments In addition the ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Automated Image-based Biomarker Computation Tools for Diabetic Retinopathy
SBC: EYENUK, INC. Topic: NCATSDESCRIPTION provided by applicant In this STTR project we present EyeMark a set of advanced image analysis tools for automated computation of biomarkers for diabetic retinopathy DR using retinal fundus images Specifically we will develop tools for computation of microaneurysm MA appearance and disappearance rates jointly known as turnover rates for use as a biomarker in quantifying D ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Biologically-inspired Integrated Vision System
SBC: SPECTRAL IMAGING LABORATORY Topic: AF12BT03ABSTRACT: The U.S. Air Force has a need to develop a new class of advanced, wide field of view (WFOV) imaging sensors that sample the radiation field in multiple modes: spectral, temporal, polarization, and detailed object shape. These multimodal sensors are to be deployed on high altitude drones to enhance their intelligence, surveillance, and reconnaissance (ISR) capabilities. Smaller versions o ...
STTR Phase II 2014 Department of DefenseAir Force -
Brain penetrant Hsp90 inhibitors for Alzheimer's disease
SBC: YUMA THERAPEUTICS CORPORAITON Topic: NIADESCRIPTION provided by applicant Neurodegeneration in Alzheimerandapos s disease AD may result from deposition of A as plaques in brain tissue However less effort has been made to elucidate the role of tau containing neurofibrillary tangles NFTs in AD Accumulating evidence suggests that tau containing NFTs is an important component in the initiation and progression of AD and other neu ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Coils for Human Whole Body Imaging at 7T
SBC: LIFE SERVICES L.L.C. Topic: NIBIBDESCRIPTION provided by applicant For this Phase II STTR proposal the investigators plan to develop and commercialize the radiofrequency RF coil technology to make T body MRI possible and to translate this new technology to vastly improve T clinical MRI as well In the Phase I project leading to this proposal all specific aims were accomplished to demonstrate the feasibility of safely an ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Development of a clinical hemoglobin modulator
SBC: Phoenicia Biosciences, Inc. Topic: NHLBIDESCRIPTION provided by applicant The thalassemias and sickle cell disease are serious genetic blood diseases which are WHO designated as a growing global health burden The disorders decrease production or alter structure of the b chain of adult hemoglobin A and are characterized by anemia chronic organ damage and early mortality HbF is another type of normal hemoglobin which is suppres ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Development of an Innovative System for Cryodeposit Mitigation and Redmediation
SBC: PHYSICAL SCIENCES INC. Topic: AF12BT10ABSTRACT: Physical Sciences Inc. (PSI) and the University of Tennessee Space Institute (UTSI) will develop an innovative system to measure and control the cryodeposit layer thickness that develops on cold (~20 K) surfaces in cryogenic radiometric calibration chambers. Currently removing the cryo-layer involves a lengthy process that warms the entire cryo-system to desorb the cryo-layer that incr ...
STTR Phase II 2014 Department of DefenseAir Force -
Development of breakthrough intra-operative detector and imaging system for parat
SBC: Anasys Instruments Corp. Topic: 102DESCRIPTION provided by applicant There are parathyroid glands in the neck and they are responsible for the production of parathyroid hormone which maintains calcium homeostasis throughout the body They are difficult to identify relative to the other tissues in the neck such s lymph nodes fat thyroid etc This has resulted in the incidence of accidental parathyroid removal ranging from ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Development of PAR2 Inhibitors for the Treatment of Nonalcoholic steatohepatitis
SBC: OASIS PHARMACEUTICALS, LLC Topic: NIDDKDESCRIPTION provided by applicant Non alcoholic steatohepatitis NASH is characterized by fatty changes in the liver with inflammation and hepatocellular injury that in advanced stages leads to fibrosis and cirrhosis and high mortality rates NASH is frequently associated with other common metabolic abnormalities such as insulin resistance and visceral obesity Liver transplantation is curren ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health